Pep2Tango Therapeutics

Pep2Tango Therapeutics is a biotechnology company developing next-generation peptide drugs to address unmet medical needs, particularly in metabolic disorders. Their focus is on unimolecular peptides targeting multiple receptors for superior weight loss efficacy and improved tolerability, offering a novel approach to obesity treatment. The company is backed by Versant Ventures and aims for clinical trials by 2025.

+ 0 Upvotes
Buy Funded Startups lists